Sheka AC, Adeyi O, Thompson J, Hameed B, Crawford PA, Ikramuddin S. Non-alcoholic steatohepatitis: a review. JAMA. 2020;323(12):1175–83.

Article  CAS  PubMed  Google Scholar 

Takahashi Y, Fukusato T. Histopathology of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis. World J Gastroenterol. 2014;20(42):15539–48.

Article  PubMed  PubMed Central  Google Scholar 

Perumpail B, Khan M, Yoo E, Cholankeril G, Kim D, Ahmed A. Clinical epidemiology and disease burden of non-alcoholic fatty liver disease. World J Gastroenterol. 2017;23(47):8263–76.

Article  PubMed  PubMed Central  Google Scholar 

Estes C, Anstee QM, Arias-Loste MT, et al. Modeling nafld disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030. J Hepatol. 2018;69(4):896–904.

Article  PubMed  Google Scholar 

Lonardo A, Byrne CD, Caldwell SH, Cortez-Pinto H, Targher G. Global epidemiology of non-alcoholic fatty liver disease. Meta-analytic assessment of prevalence, incidence and outcomes. Hepatology. 2016;64(4):1388–9.

Article  CAS  PubMed  Google Scholar 

European Association for the Study of the Liver (EASL); European Association for the Study of Diabetes (EASD); European Association for the Study of Obesity (EASO). EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. J Hepatol. 2016;64(6):1388–402.

Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, Rinella M, et al. The diagnosis and management of non-alcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 2018;67(1):328–57.

Article  PubMed  Google Scholar 

O’Hara J, Finnegan A, Dhillon H, Ruiz-Casas L, Pedra G, Franks B, Morgan G, Hebditch V, Jönsson B, Mabhala M, Reic T. Cost of non-alcoholic steatohepatitis in Europe and the USA: the GAIN study. JHEP Reports. 2020;2(5):100142.

Article  PubMed  PubMed Central  Google Scholar 

Tampi RP, Wong VW-S, Wong GL-H, Shu SS-T, Chan HL-Y, Fung J, et al. Modelling the economic and clinical burden of non-alcoholic steatohepatitis in East Asia: data from Hong Kong. Hepatol Res. 2020;50(9):1024–31.

Singh S, Allen AM, Wang Z, et al. Fibrosis progression in non-alcoholic fatty liver vs non-alcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies. Clin Gastroenterol Hepatol. 2015;13(4):643-654.e9.

Article  PubMed  Google Scholar 

Vuppalanchi R, Noureddin M, Alkhouri N, Sanyal AJ. Therapeutic pipeline in non-alcoholic steatohepatitis. Nat Rev Gastroenterol Hepatol. 2021;18(6):373–92.

Article  PubMed  Google Scholar 

Chen M, Xie Y, Gong S, Wang Y, Yu H, Zhou T, Huang F, Guo X, Zhang H, Huang R, Han Z. Traditional Chinese medicine in the treatment of non-alcoholic steatohepatitis. Pharmacol Res. 2021;172:105849.

Article  CAS  PubMed  Google Scholar 

Zhao CQ, Zhou Y, Ping J, Xu LM. Traditional Chinese medicine for treatment of liver diseases: progress, challenges and opportunities. J Integr Med. 2014;12(5):401–8.

Article  PubMed  PubMed Central  Google Scholar 

Liang Z, Chen X, Shi J, Hu H, Xue Y, Ung CO. Efficacy and safety of traditional Chinese medicines for non-alcoholic fatty liver disease: a systematic literature review of randomised controlled trials. Chin Med. 2021;16(1):1–38.

Article  Google Scholar 

Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Syst Rev. 2021;10(1):1–11.

Article  Google Scholar 

Methley AM, Campbell S, Chew-Graham C, et al. PICO, PICOS and SPIDER: a comparison study of specificity and sensitivity in three search tools for qualitative systematic reviews. BMC Health Serv Res. 2014;14(1):1–10.

Article  Google Scholar 

National Medical Products Administration of China. Chinese medicine clinical research of new drugs guiding principles. Beijing: China Medical Science and Technology Press; 2002; p. 150–1 (in Chinese).

Bastian M, Heymann S, Jacomy M. Gephi: an open source software for exploring and manipulating networks. In: Third International AAAI Conference on Weblogs and Social Media. 2009;3(1):361-362.

Shavakhi A, Torki M, Khodadoostan M, et al. Effects of cumin on non-alcoholic steatohepatitis: a double blind, randomised, controlled trial. Adv Biomed Res. 2015;4:1.

Wong VWS, Wong GLH, Chan AWH, et al. Treatment of non-alcoholic steatohepatitis with P. hyllanthus urinaria: a randomised trial. J Gastroenterol Hepatol. 2013;28(1):57–62.

Article  CAS  PubMed  Google Scholar 

Rangboo V, Noroozi M, Zavoshy R, et al. The effect of artichoke leaf extract on alanine aminotransferase and aspartate aminotransferase in the patients with non-alcoholic steatohepatitis. Int J Hepatol. 2016;1:1.

Solhi H, Ghahremani R, Kazemifar AM, et al. Silymarin in treatment of non-alcoholic steatohepatitis: a randomised clinical trial. Caspian J Intern Med. 2014;5(1):9.

PubMed  PubMed Central  Google Scholar 

Long SS, Jang W, Dong YN, Wang WQ, Li RD. Clinical observation of self-proposed Xiaopi Huatan granules combined with Silibinin capsules in the treatment of non-alcoholic steatohepatitis with Phlegm-damp internal resistance syndrome. Guiding J Tradit Chin Med and Pharm. 2022;28(2):66–70 (in Chinese).

Google Scholar 

Sun XH, Qu YZ, Zhou F, Pei C, Sun J. Clinical efficacy observation of Paizhuo Jiangmei formula and western medicine on early non-alcoholic steatohepatitis with damp-heat accumulation syndrome. Shanxi J Tradit Chin Med. 2022;38(1):23–6 (in Chinese).

Google Scholar 

Tai L, Zeng YX, Fan RY, et al. Clinical effect of Quzhi Hugan decoction in treatment of non-alcoholic steatohepatitis with damp-turbidity stagnation: An analysis of 40 cases. Hunan J Tradit Chin Med. 2022;38(3):9–12 (in Chinese).

Google Scholar 

Wang F, Gao XX, Wang QQ. Short-term efficacy of Huanglian Jiedu decoction and probiotics supplement in intervention of patients with non-alcoholic steatohepatitis. J Prac Hepatol. 2022;25(2):235–8 (in Chinese).

CAS  Google Scholar 

Chen WL, Liang F, Zhang YC, et al. Observe on curative effect of Yuzha Quzhi Qinggan prescription combined with glutathinone in treating non-alcoholic fatty liver disease. Chin J Integr Tradit West Med Liver Dis. 2021;31(3):216–8 (in Chinese).

Google Scholar 

He QS, Liu Y, Xu CJ. Observation of therapeutic effect of Myrrha on non-alcoholic steatohepatitis. Inner Mongolia J Tradit Chin Med. 2021;40(4):7–10 (in Chinese).

Google Scholar 

Jin JJ. Clinical study on Shugan Huazhuo Tang combined with routine western medicine for non-alcoholic steatohepatitis. J New Chin Med. 2021;53(5):83–96 (in Chinese).

CAS  Google Scholar 

Lei XBP, Li XY, Dai YN, et al. Clinical observation of self-made Zhiyanping granule in the treatment of 45 Cases of non-alcoholic steatohepatitis. Chin J Ethnomed Ethnopharmacy. 2021;30(5):84–7 (in Chinese).

Google Scholar 

Lei YJ, Wang LL, Ye XD, Miu MJ, Zhu XQ. Clinical study on modified Chaihu Shugan Powder combined with Polyene Phosphati-dylcholine capsules for non-alcoholic steatohepatitis. J of New Chin Med. 2021;53(15):24–8 (in Chinese).

CAS  Google Scholar 

Liu XJ, Wang Y, Wang N, Zhang T. Clinical study on modified Chaishao Liujunzi decoction in treatment of non-alcoholic steatohepatitis with liver stagnation and slpeen deficiency syndrome. Chin J Inf Tradit Chin Med. 2021;28(1):113–7 (in Chinese).

Google Scholar 

Wang WL, Yan FJ, Xu ML, Gao C. Clinical study on Jiangzhi Tongmai capsules combined with routine therapy for non-alcoholic steatohepatitis. J New Chin Med. 2021;53(3):73–6 (in Chinese).

Google Scholar 

Zhang WH, Wu J, Li QY, et al. Efficacy of Gegen Qinlian Quzhuo decoction in treating type 2 diabetes patients with non-alcoholic fatty liver and its influence on the levels of sCD36 and ADRP.Chin J Integr Tradit West Med Liver Dis. 2021;31(9):792–5 (in Chinese).

Lin XM, Chen S, Tang YQ, Yang JL. Clinical observation of 40 cases of non-alcoholic steatohepatitis with spleen deficiency, phlegm and stagnation in the treatment of liver deficiency and spleen strengthening method. China’s Naturopathy. 2020;28(21):67–71 (in Chinese).

Google Scholar 

Zhang XX, Liu YD, Yang ChC. Clinical study on the treatment of non-alcoholic steatohepatitis with liver-preserving and detoxifying soup combined with silymarin. J of Tradit Chin Med. 2020;48(10):47–51 (in Chinese).

Google Scholar 

Zhou XM, Wang H, Wang Y. Effect of phlegm-dampness recipe on liver function and blood lipid index for patients with non-alcoholic steatosis hepatitis. J Sichuan Tradit Chin Med. 2020;38(2):105–7 (in Chinese).

Google Scholar 

Lan XM, Wu YN, Chen SD, et al. Treatment of non-alcoholic steatohepatitis by Zaozhu Yinchen recipe. Chin J Integr Tradit West Med. 2019;39(5):557–80 (in Chinese).

Google Scholar 

Sun SN, Wang Y. Clinical effects of self-made Linggui Zhugan Jiajian decoction combined with western medicine in the treatment of non-alcoholic fatty liver. Med Prac. 2019;14(9):65–8 (in Chinese).

Google Scholar 

Zhou HJ, Chen G, Xie HD. Clinical evaluation of Shen Ze Shugan capsule in the treatment of non-alcoholic steatohepatitis (Damp-heat Stagnation Syndrome). Tradit Chin Drug Res and Clin Pharmacol. 2019;30(9):1133–7 (in Chinese).

CAS  Google Scholar 

Zhou YP, Yang JL, Yang P, Chen S, Guo LH, Lyu XY. Prospective cohort study of “Eight Zhes” decoction in the treatment of non-alcoholic steatohepatitis. Chin J Mod Appl Pharm. 2019;36(17):2197–201 (in Chinese).

Google Scholar 

Zou JF. Effect of Shengjiang decoction on liver function and therapeutic effect in patients with non-alcoholic steatohepatitis of liver depression and spleen deficiency type. J Prac Tradit Chin Inter Med. 2019;33(9):57–9 (in Chinese).

Google Scholar 

Cai Z, Mai JY. Clinical effects of Shenge Granules on senile non-alcoholic steatohepatitis due to Spleen Deficiency and Phlegm Turbidity. Chin Tradit Pat Med. 2018;40(9):1935–8 (in Chinese).

Google Scholar 

Chen X, Zhang JF, Sun WD, Liang RS, Lu W. Clinical study of self-made Chinese medicines in treating non-alcoholic steatohepatitis of the Pixu Tanshi type. Chin J Integr Tradit West Med Liver Dis. 2018;28(5):82–4 (in Chinese).

Google Scholar 

Fan YW, Xie WP. Effect of soothing liver and strengthening spleen therapy in treating non-alcoholic steatohepatitis and analysis of changes in BMI and AC. Chin Med Modern Distance Education Chin. 2018;16(23):57–8 (in Chinese).

Google Scholar 

Li HS, Ying H, He XL, He ZY. Clinical observation of Qutan Huoxue decoction for treating non-alcoholic steatohepatitis. Chin Arch Tradit Chin Med. 2018;36(7):1554–6 (in Chinese).

CAS  Google Scholar 

Lin L, Liang HQ, Zhuang HL, et al. Effect of Zaozhu Yinchen recipe on intestinal flora in treatment of non-alcoholic steatohepatitis. Chin J Integr Tradit West Med. 2018;38(6):673–6 (in Chinese).

Google Scholar 

Liu JR, Zhu XN, Wang J, Peng ZX, Peng MY. Clinical evaluation of eliminating phlegm and activating blood granule in treating non-alcoholic steatohepatitis with syndrome of phlegm and blood stasis. World Lasest Med Information. 2018;18(98):28–30 (in Chinese).

Google Scholar 

Liu Y, Han XZ, Xu ML, He Y. Effect of Huanglian Jiedu decoction combined with Silybin capsule on non-alcoholic steatohepatitis with Damp-heat syndrome. J Basic Chin Med. 2018;24(9):1258–61 (in Chinese).

Google Scholar 

Mai JY, Gao YQ, Cai Z, Fang MQ. Shenge recipe in the treatment of senile non-alcoholic steatohepatitis with syndrome of phlegm turbidity due to spleen deficiency: a randomised, double-blind and placebo-controlled trial. Shanghai J TCM. 2018;52(2):44–8 (in Chinese).

Google Scholar 

Wu Di, Li JX, Xie CE, et al. Observing the effect of Yinchen Linggui prescription on NASH based on liver ultrasonic attenuation parameters. Chin J Integr Trad West Med Dig. 2018;26(10):817–22 (in Chinese).

Dai HY. Clinical observation of 16 cases of spleen deficiency and dampness in non-alcoholic steatohepatitis treated with Shenling Baizhu Powder. Hunan J of Tradit Chin Med. 2017;33(3):53–5 (in Chinese).

Google Scholar 

He Z, Zhao Q, He XP, et al. Effects of Quzhi Yugan granule to aadiponectin and interleukin-6 in the non-alcoholic steatohepatitis (NASH) patients. Guizhou Med J. 2017;41(10):1025–7 (in Chinese).

CAS  Google Scholar 

Hu Y, Mou HJ, Chen K. Clinical effect observation of Jianpishugan and Huoxuehuatan formula on liver depression and spleen deficiency induced non-alcoholic steatohepatitis. J Nangjing Univ Tradit Chin Med. 2017;33(4):359–62 (in Chinese).

Google Scholar 

Jiang YY, Lin J, Dong PL, Wang XP. Treatment of non-alcoholic steatohepatitis by Dahuang Lidan capsule. Chin J Integr Tradit West Med. 2017;37(5):539–42 (in Chinese).

Google Scholar 

Liu D, Li P, Wang JL, Jiang ZL, Li S. Clinical study on effect of Yinchenhao decoction in treating no